Abstract
The cell culture approach to the study of the nervous system attempts to reduce cellular complexity to various extents and to characterize the influences of extrinsic molecules on the cell population under study. To date, the main source of culture model systems to explore CNS function and dysfunction is fetal brain material from experimental animals, typically rodents. We have developed primary microglial cell cultures and focused on the concentration-dependent effects of different amino acids and growth promoting additives on microglial morphology and function. We used Basal Medium Eagle (BME) with 1g/L of glucose instead of Dulbecco's modified Eagle medium (DMEM) as serum-free condition, since BME does not contain L-Glycine (Gly) and L-Serine (Ser), and investigated the effects of these two amino acids on microglial morphology and functions by adding various concentrations of the amino acids to BME and different concentrations of ascorbic acid (10–75 μg/ml), hydrocortisone (1–7.5 nM) and DL-α-tocopherol (0.01–0.5 μg/ml) as growth promoters. Under Gly/Ser-free, serum-free condition, and growth promoters-free conditions, the majority of rat microglial cells displayed round morphology, whereas in the presence of 5 μM Gly and 25 μM Ser, which correspond to the concentrations of Gly and Ser in the cerebrospinal fluid, they extended multiple branched processes and formed clusters of rough endoplasmic reticulum. Ascorbic acid (25 μg/ml), 2.5 nM hydrocortisone and 0.05 μg/ml of DL-α-tocopherol elicited the highest level of microglial activation as measured by an increased expression of MHC class-I and MHC class-II antigens. Neuron culture experiments using the conditioned medium obtained from the different microglial culture conditions indicate neurotoxic and neurotrophic effects depending on the concentrations of amino acids as well as on the concentration of the growth promoters. These findings suggest that resting ramified microglial cells with neurotrophic activity can be induced with the combination of BME medium and small amounts of extracellular matrix growth promoters.
Similar content being viewed by others
References
Aloisi F (2001) Immune function of microglia.Glia 36, 165–179.
Barber SA, L Bruett, BR Douglass, DS Herbst, MC Zink and JE Clements (2002) Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology.J. Virol. 76, 817–828.
Becher B, A Prat and JP Antel (2000) Brain-immune connection: immuno-regulatory properties of CNS-resident cells.Glia 15, 293–304.
Cagnin A, R Myers, RN Gunn, AD Lawrence, T Stevens, GW Kreutzberg, T Jones and RB Banati (2001)In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion.Brain 124, 2014–2027.
Campanella M, C Sciorati, G Tarozzo and M Beltramo (2002) Flow cytometric analysis of inflammatory cells in ischemic rat brain.Stroke 33, 586–592.
Cheng Y, M Chen, P Wixom and AY Sun (1994) Extracellular ATP may induce neuronal degeneration by a free radical mechanism.Ann. N.Y. Acad. Sci. 738, 431–435.
Cowell RM, H Xu, JM Galasso and FS Silverstein (2002) Hypoxicischemic injury induces macrophage inflammatory protein-lalpha expression in immature rat brain.Stroke 33, 795–801.
Eskes C, P Honegger, L Juillerat-Jeanneret and F Monnet-Tschudi (2002) Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release.Glia 37, 43–52.
Fujita H, J Tanaka, K Toku, N Tateishi, Y Suzuki, S Matsuda, M Sakanaka and N Maeda (1996) Effects of GM-CSF and ordinary supplements on the ramification of microglia in culture: a morphometrical study.Glia 18, 269–281.
Gebicke-Haerter PJ (2001) Microglia in neurodegeneration: molecular aspects.Microsc. Res. Tech. 54, 47–58.
German DC, CL Liang, T Song, U Yazdani, C Xie and JM Dietschy (2002) Neurodegeneration in the Niemann-Pick C mouse: glial involvement.Neuroscience 109, 437–450.
Giulian D and TJ Baker (1990) Characterization of ameboid microglia isolated from developing mammalian brain.J. Neurosci.6, 2163–2178.
Giulian D, K Vaca and M Corpuz (1993) Brain glia release factors with opposing actions upon neuronal survival.J. Neurosci. 13, 29–37.
Glembotski CC (1987) The role of ascorbic acid in the biosynthesis of the neuroendocrine peptides α-MSH and TRH.Ann. N.Y. Acad. Sci. 498, 54–62.
Gonzalez-Scarano F and G Baltuch (1999) Microglia as mediators of inflammatory and degenerative diseases.Ann. Rev. Neurosci. 22, 19–40.
Guo L, A Sawkar, M Zasadzki, DM Watterson and LJ Van Eldik (2001) Similar activation of glial cultures from different rat brain regions by neuroinflammatory stimuli and downregulation of the activation by a new class of small molecule ligands.Neurobiol Aging 22, 975–981.
Kuhlmann T, U Wendling, C Nolte, F Zipp, B Marushak, C Stadelmann, H Siebert and W Bruck (2002) Differential regulation of myelin phagocytosis by macrophage/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins.J. Neurosci. Res. 67, 185–190.
Lee WH, SH Kim, EM Jeong, YU Choi, DI Kim, BB Lee, YS Cho, BS Kwon and JE Park (2002) A novel chemokine, Leukotactin-1, induces chemotaxis, proatherogenic cytokines, and tissue factor expression in atherosclerosis.Atherosclerosis 161, 255–261.
Lenzlinger PM, MC Morganti-Kossmann, HL Laurer and TK McIntosh (2001) The duality of the inflammatory response to traumatic brain injury.Mol. Neurobiol. 24, 169–181.
Ling EA, YK Ng, CH Wu and C Kaur (2001) Microglia: its development and role as a neuropathology sensor.Prog. Brain Res. 132, 61–79.
Lombardi VRM, M García and R Cacabelos (1998) Microglial activation induced by factor(s) contained in sera from Alzheimerrelated APOE genotypes.J. Neurosci. Res. 54, 539–553.
Maneiro E, VRM Lombardi and R Cacabelos (1996) Rat cell cultures: experimental models to study neurodegenerative disorders and new pharmacological compounds.Meth. Find. Exp. Clin. Pharmacol. 18, 615–645.
Meda L, MA Cassatella, GI Szendrei, L Otvos, P Baron, M Villalba, D Ferrari and F Rossi (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma.Nature 374, 647–650.
Meda L, P Baron and G Scarlato (2001) Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins.Neurobiol. Aging 22, 909–913.
Miller BT and TJ Cicero (1987) Ascorbate-induced release of LHRH: noradrenergic and opioid modulation.Brain Res. Bull. 19, 95–99.
Mun-Bryce S, A Lukes, J Wallace, M Lukes-Marx and GA Rosemberg (2002) Stromelysin-1 and gelatinase A are upregulated before TNF—α in LPS-stimulated neuroinflammation.Brain Res. 12, 42–49.
Nau R and W Bruck (2002) Neuronal injury in bacterial meningitis: mechanisms and implications for therapy.Trends Neurosci. 25, 38–45.
Piani D, K Frei, KQ Do, M Cuénod and A Fontana (1991) Murine brain macrophages induce NMDA receptor mediated neurotoxicityin vitro by secreting glutamate.Neurosci. Lett. 133, 159–162.
Polazzi E, T Gianni and A Contestabile (2001) Microglial cells protect cerebellar granule neurons from apoptosis: evidence for reciprocal signaling.Glia 36, 271–280.
Rezaie P, G Trillo-Pazos, J Greenwood, IP Everall and DK Male (2002) Motility and ramification of human fetal microglia in culture: an investigation using time-lapse video microscopy and image analysis.Exp. Cell. Res. 274, 68–82.
Streit WJ, JR Conde and JK Harrison (2001) Chemokines and Alzheimer's disease.Neurobiol. Aging 22, 885–893.
Ullrich O, A Diestel, IY Eyupoglu and R Nitsch (2001) Regulation of microglial expression of integrins by poly (ADP-ribose) polymerase-1.Nature Cell Biol. 12, 1035–1042.
Vaca K and E Wendt (1992) Divergent effects of astroglial and microglial secretions on neuron growth and survival.Exp. Neurol. 118, 62–72.
Varon S (1975) Neurons and glia in neural cultures.Exp. Neurol. 48, 93–104.
Yu W, L Go, BA Guinn, PE Fraser, D Westaway and J McLaurin (2002) Phenotypic and functional changes in glial cells as a function of age.Neurobiol. Aging 23, 105–115.
Wu DC, V Jackson-Lewis, M Vila, K Tieu, P Teismann, C Vadseth, DK Choi, H Ischiropoulos and S Przedborski (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.J. Neurosci. Res. 22, 1763–1771.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lombardi, V.R.M., Etcheverría, I., Fernández-Novoa, L. et al. In vitro regulation of rat derived microglia. neurotox res 5, 201–211 (2003). https://doi.org/10.1007/BF03033140
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03033140